v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Paid-In Capital
Retained Earnings
Unearned ESOP Shares
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Jun. 30, 2024   64,434,000        
Balance at beginning of period at Jun. 30, 2024 $ 753,571 $ 644 $ 493,680 $ 343,326 $ (20,916) $ (63,163)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income 19,306     19,306    
Other comprehensive loss, net of income tax (5,965)         (5,965)
ESOP shares committed to be released 1,052   (407)   1,459  
Issuance of stock under stock benefit plans (in shares)   207,000        
Issuance of stock under stock benefit plan   $ 2 (2)      
Stock-based compensation expense 1,209   1,209      
Cancellation of shares issued for restricted stock awards (in shares)   (61,000)        
Cancellation of shares issued for restricted stock awards (349)   (349)      
Cash dividends declared (20,711)     (20,711)    
Balance at end of period (in shares) at Mar. 31, 2025   64,580,000        
Balance at end of period at Mar. 31, 2025 748,113 $ 646 494,131 341,921 (19,457) (69,128)
Balance at beginning of period (in shares) at Dec. 31, 2024   64,580,000        
Balance at beginning of period at Dec. 31, 2024 744,853 $ 646 494,092 342,155 (19,943) (72,097)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income 6,648     6,648    
Other comprehensive loss, net of income tax 2,969         2,969
ESOP shares committed to be released 343   (143)   486  
Stock-based compensation expense 182   182      
Cash dividends declared (6,882)     (6,882)    
Balance at end of period (in shares) at Mar. 31, 2025   64,580,000        
Balance at end of period at Mar. 31, 2025 $ 748,113 $ 646 494,131 341,921 (19,457) (69,128)
Balance at beginning of period (in shares) at Jun. 30, 2025 64,577,481 64,577,000        
Balance at beginning of period at Jun. 30, 2025 $ 745,962 $ 646 494,546 341,744 (18,970) (72,004)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income 29,092     29,092    
Other comprehensive loss, net of income tax 6,576         6,576
ESOP shares committed to be released 1,056   (403)   1,459  
Issuance of stock under stock benefit plans (in shares)   238,000        
Issuance of stock under stock benefit plan   $ 2 (2)      
Stock-based compensation expense 1,716   1,716      
Cancellation of shares issued for restricted stock awards (in shares)   (76,000)        
Cancellation of shares issued for restricted stock awards (415)   (415)      
Cash dividends declared $ (20,955)     (20,955)    
Balance at end of period (in shares) at Mar. 31, 2026 64,739,151 64,739,000        
Balance at end of period at Mar. 31, 2026 $ 763,032 $ 648 495,442 349,881 (17,511) (65,428)
Balance at beginning of period (in shares) at Dec. 31, 2025   64,739,000        
Balance at beginning of period at Dec. 31, 2025 757,396 $ 648 494,959 346,749 (17,997) (66,963)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income 10,137     10,137    
Other comprehensive loss, net of income tax 1,535         1,535
ESOP shares committed to be released 387   (99)   486  
Stock-based compensation expense 582   582      
Cash dividends declared $ (7,005)     (7,005)    
Balance at end of period (in shares) at Mar. 31, 2026 64,739,151 64,739,000        
Balance at end of period at Mar. 31, 2026 $ 763,032 $ 648 $ 495,442 $ 349,881 $ (17,511) $ (65,428)